1.1.5.4: malate dehydrogenase (quinone)
This is an abbreviated version!
For detailed information about malate dehydrogenase (quinone), go to the full flat file.
Word Map on EC 1.1.5.4
-
1.1.5.4
-
oxaloacetate
-
glutamicum
-
phospholipid-requiring
-
pyrroloquinoline
-
lipid-depleted
-
1.1.1.37
-
biotechnology
- 1.1.5.4
- oxaloacetate
- glutamicum
-
phospholipid-requiring
-
pyrroloquinoline
-
lipid-depleted
-
1.1.1.37
- biotechnology
Reaction
Synonyms
EC 1.1.3.3, EC 1.1.99.16, FAD-dependent malate dehydrogenase, L-malate-quinone oxidoreductase, L-malate:quinone oxidoreductase, malate dehydrogenase, malate dehydrogenase (acceptor), malate-quinone oxidoreductase, malate-vitamin K reductase, malate: quinone oxidoreductase, malate:quinine oxidoreductase, malate:quinone oxidoreductase, malate:quinone reductase, menaquinone reductase, Mqo, MqoB, MQR, PfMQO
ECTree
Advanced search results
Inhibitors
Inhibitors on EC 1.1.5.4 - malate dehydrogenase (quinone)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
(S)-malate
-
in the presence of polymyxin B, enzyme kinetics changes from the Michaelis-Menten type to substrate inhibition kinetics with the substrate inhibition constant Ksi of 57.4 microg/ml
1,1'-[furan-2,5-diylbis(3-chloro-1,4-phenylene)]bisguanidine
inhibits growth of cultured parasite
-
2-cycloheptyl-5-[4-methoxy-3-[4-[4-(2H-tetrazol-5-yl)phenoxy]butoxy]phenyl]-4,4-dimethylpyrazol-3-one
inhibits growth of cultured parasite
-
2-[3-chloro-4-[5-[2-chloro-4-(diaminomethylideneamino)phenyl]furan-2-yl]phenyl]guanidine
inhibits growth of cultured parasite
-
3-cycloheptyl-4abeta,5,8,8abeta-tetrahydro-1-[3-[4-[4-(2H-tetrazole-5-yl)phenoxy]butoxy]-4-methoxyphenyl]phthalazine-4(3H)-one
inhibits growth of cultured parasite
-
3-[7-[(3,5-dimethylbenzyl)oxy]-4,8-dimethyl-2-oxo-2H-chromen-3-yl]propanoic acid
-
-
5-bromo-2-chloro-N-(5-mercapto-1,3,4-thiadiazol-2-yl)benzamide
-
-
ferulenol
inhibits parasite growth and shows strong synergism in combination with atovaquone, an anti-malarial and bc1 complex inhibitor
-
Polymyxin B
-
cationic decapeptide. Primary site of action is the quinone-binding site, amino acid sequence is examined and possible binding sites for L-malate and quinones are found
Sodium amytal
-
1 mM, competitive with respect to phosphatidylethanolamine, noncompetitive with respect to FAD
additional information
-
o-phenanthroline does not significantly affect activity
-